Protocol No.: EAA173
- Title
- Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma
- Principal Investigator
- Veltri, Lauren
- Phase
- III
- Age Group
- Adult
- Applicable Disease Site
- Multiple Myeloma
- Participating Institution
- Mary Babb Randolph Cancer Center
- Contacts
- Kristin Volk, RN
- Research Nurse
- Phone: +1 304-581-1893
- Email: kristin.volk@hsc.wvu.edu
- Maher Kali, MD
- Clinical Research Specialist
- Phone: +1 304-243-7045
- Email: maher.kali@wvumedicine.org